Author: admin

The Spanish society of physical medicine and rehabilitation and the Societat Catalana of Rehabilitació I physical medicine demand the revision of the ERE of mutual Terrassa.

|

The Spanish society of rehabilitation and physical medicine and the Societat Catalana of Rehabilitació I physical medicine are calling for the revision of the ERE Mútua Terrassa.

in defense of healthcare to patients and specialty medical.

-the ERE of mutual Terrassa reaches 97% of the rehabilitation service of this Center, affecting thus rehabilitative (400,000 inhabitants) area health coverage and rehabilitation processes in course

– the quality of health care will be very embittered if finally is carried out as, leading to physical and psychic disorders patients from this service

-the measure will lead to important consequences for the public sector because of predictable delays that occur as a result of the increase in periods of low, and the economic impact of the derivations of these sick

-the record of employment regulation affects doctors, physiotherapists, nurses, occupational therapists, speech therapists, foniatras, auxiliary and administrative staff

– there is the added fact that this service is a unit Acreditada teacher by the Ministry of education for the formation of internal resident doctors (MIR) in this specialty. Also carries out a research activity of high technical quality

Barcelona, July of 2011- the Spanish society of rehabilitation and physical medicine (SERMEF) and the Societat Catalana of Rehabilitació i physical medicine have sent a joint letter to the various entities involved in the approval of the record of employment (ERE) submitted by the Hospital Universitari mutual Terrassa Regulation)(HUMT) on 30 June, in order to reconsider his acceptance. said ERE is the dismissal of 71 73 professionals that make up this hospital rehabilitation services, which affects the rehabilitative health coverage from a population that exceeds 400,000 persons, as well as the numerous rehabilitation proceedings currently under way.

Two scientific societies claim in his writing to the Hospital Universitari mutual Terrassa the withdrawal of its request for ERE or, in the case of moving forward, keep operating the service of rehabilitation, in order to avoid the negative impact on the health coverage of more than 400,000 people living in the municipalities of Terrassa-St.QuirzeRubí, Valldoreix and Mirasol, St. Cugat, La Floresta and Les plans; for certain diseases, such as the neuroquirúrgicas or thoracic surgery, the population reaches 1 million inhabitants.

The Spanish society of physical medicine and rehabilitation and the Societat Catalana of Rehabilitació i physical medicine have jointly submitted letters to the Minister of health of the Generalitat de Catalunya, the Mayor of the City Council of Terrassa and to the President of mutual Terrassa, calling for the revision of the ERE. Both entities show your “ indignation and astonishment at the grave health situation that the closure of the rehabilitation service will generate ”, and whose impact on the health of the population of the area are eligible for a “ tremendous irresponsibility ”.

Of carrying out the case of proposed employment regulation, service of rehabilitation of mutual Terrassa, including outpatient, hospital rehabilitation and geriatric care, would be completely dismantled. This service currently working doctors, physiotherapists, nurses, occupational therapists, speech therapists, foniatras, auxiliary and administrative staff.

Health, economic and labour cost

The scientific societies of rehabilitation and physical medicine have indicated that “ without continuity of rehabilitative treatment interruption will be sequels and irreparable deficits in patients, which will have impact on their quality of life, especially in the more fragile: children and the elderly, which are also the most common users of these services ”.

Also have shown that the implementation of the ERE will be “ delays ” job recovery “ of workers affected by trauma or disease requiring rehabilitation ”. They have also alluded to the “ economic impact of the derivations of these sick ”, and the impact “ in the quality of life ” patients and “ physical and psychic disorders that will mean all these patients, referral and care assistance elsewhere ”.

Educational unit accredited training MIR

Given the fact that, in addition to its vast health care activity, rehabilitation of mutual Terrasa is an educational unit accredited by the Ministry of education for the formation of internal resident doctors (MIR) in the specialty of physical medicine and rehabilitation. Also, this service has highlighted so far to develop a relevant research activity “ of high technical quality, and that has been raised to this service at a very high level of efficiency and quality ”.

Are currently treated in rehabilitation of mutual Terrassa service patients suffering from neurological and neuromuscular diseases (stroke, head injury, spinal cord injury, spina bifida, multiple sclerosis, amyotrophic lateral sclerosis, infantile cerebral palsy, párkinson, etc.), heart disease (ischemic heart disease)(, etc.), diseases of the apparatus locomotive (such as osteoarthritis, lumbago, tendonitis, rheumatoid arthritis, Spondyloarthropathies, inflammatory diseases of the connective tissue, politraumatismos, scoliosis, fibromyalgia and osteoporosis), diseases of the vascular and lymphatic system, well as other pathologies various or rare.

Read More
You can study Anatomy on your mobile phone by just 13, 99€!

You can study Anatomy on your mobile phone by just 13, 99€!

|

now you can study Anatomy on your mobile phone by just 13, 99€!

-The chips of self-assessment of Anatomy of GILROY, now available for your iPhone

– with more than 200 images, 1500 labels, questions and answers themed

Madrid, 2011-March health science students now have the best tool for the study of Anatomy: self-assessment of Anatomy of Gilroy in mobile chips

After posting to Spanish PROMETHEUS, mother of the anatomy of the work, Publisher medical Pan-American released the chips of self-assessment of GILROY, the perfect complement to the practical study of the anatomy.

these chips are now available in version iPhone

an application designed so that students can over and over again review the silent figures with their respective signs before consulting the answers. All images are identified with the page number corresponding to the Prometheus, Atlas Anatomy Gilroy, self-assessment cards.

This interactive guide contains a selection of the most representative images and is structured into 4 sections: back, abdomen and pelvis, upper limb and lower limb.

illustrators of Prometheus, winners of multiple awards, have created a new standard of excellence in illustrations of Anatomy: reproduce with fidelity anatomical preparations real better than ever before showing the detail demanded by the study of this discipline.

To learn about the application, you can download a free demo at: http://itunes.apple.com/es/app/gilroy-version-gratuita/id401225959?mt=8 which you know the quality of the images and test it.

the full version contains over 200 images and 1500 labels and also includes questions and answers themed images. The application can be purchased onsite APP: http://itunes.apple.com/es/app/prometheus-gilroy/id398901344?mt=8

more information.

Read More

María José Giménez, new President of AlergoSur alergóloga.

|

Alergóloga María José Giménez, new President of AlergoSur.

-Málaga natural is the first woman to preside over this scientific society

-the new Board of Directors, acting as the annual meeting held recently in Seville, AlergoSur XL has as I challenge to improve the current map of the allergy in Andalusia

– “ want allergic patients have the same opportunities in specialized medical care as in other autonomous communities”

Seville, July of 2011- the Andalusian society of Allergology and Clinical Immunology (Alergosur), which held the past weekend your XL annual meeting in Seville, meeting attended by 200 specialists, has been its Executive Board chairs the Dr. María José Giménez.

The native of Malaga alergóloga is the first woman President of the scientific society. “ The new working group posed as a challenge progress in better care of the allergic patient so this can have the same opportunities in specialized medical care as in other autonomous communities ”, explains the new President of AlergoSur.

“ Want to promote the specialty of allergy in all health care, scientific and participatory levels in society in general. To this end, we want to create more prevalent specific committees of some diseases such as asthma and food allergies, which will allow greater participation of AlergoSur in health care processes requiring a higher implementation ”, adds.

Dr. María José Giménez

one of the challenges of the team chaired by Dr. María José Giménez is “ further encourage the participation of AlergoSur in health programs and registries that currently has the Ministry of health and affecting the allergic disease such as the healthcare process of asthma, the registration of patients in air (food allergy and Anaphylaxis) program or registry of patients with rare diseases, among others ”.

Giménez also explains that his intention was “ move to the Andalusian public health system need to position our Allergists in the SAS services portfolio, reviewing each of the eight Andalusian provinces, to facilitate the meeting between the Group of professional specialists in allergy and citizens who need his assistance. From here went availability and collaboration to improve the current map of the allergy in Andalusia ”.

Also, the new President of AlergoSur has highlighted that it begins this new task with “ illusion, wanted to work with hope ” because “ want the very best in quality of care, training, scientific activity and all the activities involved in allergy in Andalusia ”.

AlergoSur is a scientific organization made up of professional specialists in allergy in order to promote the study and the improvement in the treatment of allergic disease in Andalusia.

Curriculum vitae of the specialist

María José Giménez Romero holds a degree in medicine and surgery from the University of Malaga. Specialising in Allergology as MIR conducted at the Hospital Universitario Virgen Macarena of Sevilla.

She is graduated in healthcare management by the Andalusian School of public health and he has done a PhD in paediatrics.

It belongs to the optional upper body in medicine of the Junta de Andalucía. He has continued his training with training programs accredited by the Spanish society of Allergy and Clinical Immunology (SEAIC), European Academy of Allergy and reception of health of the Board of Andalusia.

New Board policy AlergoSur

currently operates medical allergy with diverse practice tasks: asthma, immunotherapy, food allergy, Pediatric allergy, allergy skin and labor, along with specific research is such areas.

He is a member of the SEAIC for 18 years. He is currently a member of the Committee of asthma, Member of AlergoSur and member of the SAMFYC.

In recent years he has compatibilizado his activity as a specialist in allergy with primary health care (General Medicine and Pediatrics) and healthcare management.

Read More

Air Liquide signed a collaboration agreement with the European Federation of associations of patients with respiratory illnesses or allergies.

|

Air Liquide signed a collaboration agreement with the European Federation of associations of patients with respiratory illnesses or allergies.

Spain, June of 2011- Air Liquide, the world leader in gases for industry, health and the environment has signed a collaboration agreement with the EFA (European Federation of Allergy and Airways Diseases Patients Associations). This Brussels-based European Federation brings together national associations of patients suffering from respiratory conditions (22 countries represented with 500,000 members).

in the framework of this partnership, Air Liquide supports the efforts undertaken by the EFA to inform and sensitize public opinion and the European authorities about lung disease chronic (COPD) obstructive. This pathology, subdiagnosticada, represents a major public health challenge that the World Health Organization provides that in 2015 COPD happen from the 4th to the 3rd cause of death in the world. In Europe, the total cost of COPD is estimated at 45 billion euros.

Air Liquide, care home, European leader in Europe serves some 500,000 patients with apnea and inadequacies respiratory, particularly patients with COPD severe treatment of oxygen of long duration. Air Liquide works daily for better access to home care and the improvement of the quality of life of patients affected by diseases Chronicles.

Pascal Vinet, Director worldwide the Medicinal activity and activity group Medicinal operations, stated: “ this collaboration with EFA reflects our commitment to patients and our concern to respond to their needs. The dialogue between all the parties concerned – associations of patients, professionals of the health, scientific societies, industrial, taxpayers and public authorities in the health sector – is essential for better care to patients and to fight effectively against the growth of respiratory diseases ”.

DRA. Marianella Salapatas, President of the EFA has indicated: “ with the agreement of collaboration with the EFA Air Liquide contributes significantly to improve the situation of those affected by lung disease and we are grateful for this ”.



Air Liquide.

it is a world leader in gases for industry, health and the environment and is present in 80 countries with 43,600 employees. Oxygen, nitrogen, hydrogen and the noble gases are at the heart of the activity of Air Liquide since its creation in 1902. As these molecules, Air Liquide continually reinvents its business to anticipate the challenges of their present and future markets. The Group innovates to make possible the progress at the time that excels in jointly achieving dynamic growth and regularity in their results

innovative technologies for limiting emissions, reduce energy consumption in industry, put to value natural resources or develop energies of tomorrow, such as hydrogen, biofuels and photovoltaics … oxygen for hospitals, home care, contribute to the fight against nosocomial diseases … Air Liquide combines several products with different technologies to develop applications and services with strong added value for its clients and society.

a partner for the long term. The Group relies on the commitment of its employees, the confidence of its customers and the support of its shareholders to develop a competitive growth strategy’s long-term vision. The diversity of its teams, activities, markets and geographical presence ensures the strength and sustainability of their development, and strengthens its ability to continuously conquer new territories to overcome your own limits, and build their future.Air Liquide explores the best that the air can offer to preserve life, maintaining a dynamic of sustainable development. In 2010, its turnover reached 13,500 million EUR of which more than 80% out of France. Air Liquide is listed on the stock exchange of Euronext Paris (compartment A) and part of the CAC index 40 et Dow Jones Euro Stoxx 50.


Read More

The effects of sublingual immunotherapy with allergens are kept four years after starting treatment.

|

the effects of sublingual allergen immunotherapy are kept four years after starting treatment.

Congress of the European Academy of Allergy and Clinical Immunology (eaaci) Symposium “ a new era in allergen immunotherapy ”

-the results of a clinical trial conducted in adult long-term show a reduction of all symptoms to be treated with Oralair ®, tablets of sublingual immunotherapy for allergic rhinoconjunctivitis caused by pollen of grasses

Madrid, 2011-June the results of a multicentre phase III-long-term, presented at the Congress of the European Academy of Allergy and Clinical Immunology (EAACI), have shown that the effects of Oralair ®, sublingual immunotherapy as tablets for allergic rhinoconjunctivitis caused by pollen of grasses and managed with a pre-coestacional Protocolthey are kept within three years of treatment and a year after the end of the same. The reduction of all allergic symptoms observed in adults who participated in this study, he remained during the three years that were receiving the tablets of 300IR and Oralair ® in the first year post-treatment.

Dr. Sabina Rak, of the Sahlgrenska University Hospital in Gothenburg (Sweden), who participated in the Symposium of Stallergenes “ A new era in allergen immunotherapy ” explained how the researchers had carried out this study aimed to evaluate the long-term effectiveness of the tablets for sublingual immunotherapy of grasses 5 adult with allergic rhinoconjunctivitis caused by grass pollen. 633 Patients were divided into three groups, the first group to receive placebo and the remaining two Oralair ®, starting with the treatment four and two months before the pollen season, respectively.

To evaluate the results, researchers used as a main criterion the adjusted average score of symptoms (AAdSS). The analysis of the fourth year, medium-sized differences from placebo in two treatment groups were of a – 22.9% (p = 0. 0112) for the Group of four months and a – 28.5% for group of two months (p = 0. 0019). Adverse effects were not recorded during the first year free treatment or in earlier periods. “ This test – assured Dr. Rak – it has shown long-term efficacy of treatment with tablets of sublingual immunotherapy of five grass, suggesting an increased efficiency with the passing of the seasons. However, the study still is not over, because in its fifth year, we will evaluate the effect of Oralair ® on a second free treatment station ”.

At the same Symposium doctor Pascal Demoly, allergist in the University Hospital of Montpellier (France), addressed the false beliefs about allergen immunotherapy and concluded that “ despite the recent progress in the understanding of the allergy, still allergen immunotherapy should fight against false beliefs that are not justified ”said the expert. “ The high level of clinical evidence that we have currently endorses the efficacy and safety of allergen immunotherapy and enables professionals to implement it in their daily practice, thus entering a new era in the treatment of allergy ”.

About Stallergenes

Stallergenes S.A. is a biopharmaceutical company international, a leader in the manufacture and innovation of allergen immunotherapy treatments. Stallergenes sells its products to prevent and control the allergic disease in 50 countries by more than 10 subsidiaries in Europe and 40 agreements of distribution and collaboration around the world.

Stallergenes in Antony (Íle-de-France) factory is the major centre of production of allergens prepared specially for a patient (APEP) in the world, making it more than 150 different allergens to treat some 500,000 patients annually.

More than 20% of the annual turnover of the pharmaceutical company is aimed at research and development. Stallergenes turnover volume of 216 million euros in 2010.

Stallergenes Ibérica S.A. is the subsidiary of Stallergenes S.A. in our country Stallergenes Ibérica S.A. owns one portfolio of products for the treatment of 95% of patients affected by respiratory allergic diseases and it has been, since its implementation in Spanish territory for 11 years, by a strong work of research in new products

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips